AstraZeneca Archives | Be Korea-savvy
Samsung Biologics Tentatively Agrees to Work with AstraZeneca on Contract Manufacturing

Samsung Biologics Tentatively Agrees to Work with AstraZeneca on Contract Manufacturing

SEOUL, Aug. 12 (Korea Bizwire) — Samsung Biologics Co., the biotech arm of South Korea’s Samsung Group, said Friday it has tentatively agreed to work with multinational pharmaceutical company AstraZeneca on biopharmaceutical contract manufacturing. The company said in a regulatory filing that it signed a letter of intent on the cooperation in a deal valued [...]

Samsung Biologics, AstraZeneca Shutting Down Their Joint Venture Archigen Biotech

Samsung Biologics, AstraZeneca Shutting Down Their Joint Venture Archigen Biotech

SEOUL, May 24 (Korea Bizwire) — Samsung Biologics Co., the biotech arm of South Korea’s Samsung Group, is shutting down its joint venture with multinational pharmaceutical company AstraZeneca Plc., a company official said Tuesday, due to the suspension of the development of a biosimilar product. The move came two months after Samsung Biologics’ board approved [...]

AstraZeneca PLC – ADR to Join the NASDAQ-100 Index Beginning February 22, 2022

AstraZeneca PLC – ADR to Join the NASDAQ-100 Index Beginning February 22, 2022

NEW YORK, Feb. 10 (Korea Bizwire) — Nasdaq (Nasdaq: NDAQ) today announced that AstraZeneca PLC – ADR (Nasdaq: AZN), will become a component of the NASDAQ-100 Index® (Nasdaq: NDX) and the NASDAQ-100 Equal Weighted Index (Nasdaq: NDXE) prior to market open on Tuesday, February 22, 2022. AstraZeneca PLC – ADR will replace Xilinx, Inc. (Nasdaq: XLNX) [...]

Samsung Biologics to Manufacture AstraZeneca’s COVID-19 Antibody Combination

Samsung Biologics to Manufacture AstraZeneca’s COVID-19 Antibody Combination

SEOUL, Dec. 14 (Korea Bizwire) — British-Swedish pharmaceutical giant AstraZeneca said Tuesday that Samsung Biologics Co., the biotech arm of Samsung Group, will manufacture its antibody combination against COVID-19. Under an agreement valued at approximately US$380 million, Samsung Biologics will manufacture AZD7442 — AstraZeneca’s combination of two long-acting antibodies in development for the potential treatment [...]

Experts Divided over Decision to Offer AstraZeneca Vaccine Those in 30s and 40s

Experts Divided over Decision to Offer AstraZeneca Vaccine Those in 30s and 40s

SEOUL, Aug. 19 (Korea Bizwire) — Medical experts are divided over the government’s decision to alleviate age requirements for the AstraZeneca’s COVID-19 vaccine, which was originally available only to those over 50 years of age. The Korea Disease Control and Prevention Agency introduced new measures last week that allow citizens over 30 years of age [...]

S. Korea Allows Administration of Leftover AstraZeneca Vaccine Doses to Younger Population

S. Korea Allows Administration of Leftover AstraZeneca Vaccine Doses to Younger Population

SEOUL, Aug. 13 (Korea Bizwire) – South Korea on Friday allowed administration of leftover AstraZenenca COVID-19 vaccine doses to people aged 30 and over amid concerns over unused vaccines being wasted, health authorities said. The country had so far only allowed vaccines manufactured by British-Swedish pharmaceutical giant AstraZeneca and Oxford University to people aged 50 [...]

DARE-19 Phase III Collaboration Between AstraZeneca, Saint Luke’s Mid America Heart Institute and George Clinical Shows Treatment’s Well-Established Safety Profile was Consistent in Patients with COVID-19

DARE-19 Phase III Collaboration Between AstraZeneca, Saint Luke’s Mid America Heart Institute and George Clinical Shows Treatment’s Well-Established Safety Profile was Consistent in Patients with COVID-19

OVERLAND PARK, KS, July 29 (Korea Bizwire) — The findings of DARE-19, a double-blind, placebo-controlled Phase III trial examining Dapagliflozin in patients with cardiometabolic risk factors hospitalized with COVID-19, have been published in The Lancet Diabetes & Endocrinology.  The study was a collaboration of  George Clinical, a global scientifically-backed clinical research organization and Saint Luke’s Mid [...]

S. Korea to Start Vaccinations of Care Workers, Airline Crews

S. Korea to Start Vaccinations of Care Workers, Airline Crews

SEOUL, April 18 (Korea Bizwire) — South Korea will start giving AstraZeneca’s COVID-19 vaccine to health care workers and airline crews this week to speed up the vaccination drive against the pandemic, the health authority said Sunday. Health authorities will administer AstraZeneca vaccines to health care workers for the disabled, seniors and veterans as well [...]